Pharmacological activation of sphingosine 1-phosphate receptor 1 (S1pr1) enhances arteriole formation and improves cardiac function after myocardial infarction (MI)
Microencapsulated insulin-like growth factor 1 improves cardiac function after experimental myocardial infarction in comparison to low-dose mesenchymal stem cells